People: Becton Dickinson and Co (BDX)

BDX on New York Consolidated

118.61USD
23 Jul 2014
Price Change (% chg)

$0.37 (+0.31%)
Prev Close
$118.24
Open
$118.26
Day's High
$118.73
Day's Low
$118.12
Volume
506,871
Avg. Vol
714,463
52-wk High
$120.66
52-wk Low
$96.73

Search Stocks

Forlenza, Vincent 

Brief Biography

Mr. Vincent A. Forlenza is Chairman of the Board, President, Chief Executive Officer of Becton Dickinson And Co. Mr. Forlenza joined BD in 1980 and has held leadership positions in the United States and Europe. These include appointments as President of Becton Dickinson Microbiology Systems in 1996; Senior Vice President, Technology, Strategy and Development in 1998; President of BD Biosciences in 2003; and Executive Vice President in 2006, during which he was responsible for the BD Diagnostics segment. Mr. Forlenza was named President in January 2009, assumed additional responsibility as Chief Operating Officer in July 2010, and became Chief Executive Officer in October 2011 and Chairman of the Board in July 2012. Mr. Forlenza is active in various professional and community associations. In October 2010, he was appointed chairman of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that focuses solely on in-vitro diagnostic technologies. He also serves on the AdvaMed Board. Mr. Forlenza currently serves as chairman of The Valley Hospital Board of Trustees. He is a member of the Advisory Board for the P.C. Rossin College of Engineering and Applied Sciences at Lehigh University and is a member of the Board of Trustees at Lehigh. Mr. Forlenza obtained his bachelor’s degree in chemical engineering from Lehigh University in 1975 and his MBA from Wharton Graduate School, University of Pennsylvania in 1980.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
2,155,000 -- 3,270,030 9,183,030

Options Compensation

  Quantity Market Value
Exercisable 223,303 8,455,960.00
Unexercisable 62,561 1,395,020.00
Exercised 26,000 1,277,870.00
Name Fiscal Year Total

Vincent Forlenza

9,183,030

Christopher Reidy

288,974

Alexandre Conroy

--

James Lim

--

William Kozy

5,383,010

Gary Cohen

2,100,130
As Of 29 Sep 2013
Search Stocks